Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates

Keyphrases

• Vaccine Candidate 100%
• Rift Valley Fever Virus 100%
• Virus Vaccine 40%
• Virus 30%
• Protective Immunity 20%
• Vaccination 20%
• Live Attenuated 20%
• Rift Valley Fever 20%
• Ruminants 20%
• Formalin-inactivated Vaccine 20%
• North America 10%
• Infected Cells 10%
• Live Attenuated Vaccine 10%
• Novel Vaccines 10%
• Health Status 10%
• Arbovirus 10%
• Febrile Illness 10%
• Systemic Infection 10%
• Neurovirulence 10%
• Viral Outbreaks 10%
• Hemorrhagic Fever 10%
• Acute Febrile Illness 10%
• Human Population 10%
• Saudi Arabia 10%
• North Europe 10%
• Invasiveness 10%
• Africa 10%
• Replication-defective 10%
• Kenya 10%
• Mosquito Bite 10%
• Enzootic Cycle 10%
• Abortion 10%
• Yemen 10%
• Madagascar 10%
• Eastern Region 10%
• African Continent 10%
• Hemorrhagic Encephalitis 10%
• Western Africa 10%
• Southern Africa 10%
• Effective Tool 10%
• Effective Rate of Protection 10%
• Great Rift Valley 10%

Immunology and Microbiology

• Rift Valley Fever Virus 100%
• Virus Mutant 100%
• Virus Vaccine 40%
• Virus 30%
• Rift Valley Fever 20%
• Inactivated Vaccine 20%
• Replication 20%
• Encephalitis 10%
• Attenuated Vaccine 10%
• Live Vaccine 10%
• Arbovirus 10%
• Hemorrhagic Fever 10%
• Acute Febrile Illness 10%
• Health Status 10%
• Infection 10%